Vertex Pharmaceuticals' shares rose on UK approval for Alyftrek, but Tesla, NVIDIA, and Coinbase plummeted

From Nasdaq.: 2025-03-11 09:22:00

Shares of Vertex Pharmaceuticals Incorporated rose 2.4% after its cystic fibrosis drug Alyftrek received approval in the United Kingdom. Tesla, Inc. shares plummeted 15.4% due to a broad-based stock market decline. NVIDIA Corporation shares slid 5.1% as tech stocks, including mega-cap growth stocks, were affected by recession fears. Coinbase Global, Inc. shares dropped 17.6% due to perceived weakness in Bitcoin.

Zacks’ Research Chief has identified the top stock most likely to double in the coming months. This innovative financial firm with a rapidly growing customer base and cutting-edge solutions is poised for significant gains. Other Zacks picks like Nano-X Imaging, which increased by +129.6% in 9 months, highlight the potential for big returns in this stock. Download the free report to see the top stock and 4 runners-up.



Read more at Nasdaq.: Company News for Mar 11, 2025